1. Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts
    Ana R. Coelho et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  2. Combination Loading of Doxorubicin and Resveratrol in Polymeric Micelles for Increased Loading Efficiency and Efficacy
    Katherine E. Washington et al, 2018, ACS Biomater. Sci. Eng. CrossRef
  3. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes
    Teresa Cunha-Oliveira et al, 2018, Toxicology and Applied Pharmacology CrossRef
  4. LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy
    Yan Xia et al, 2017, Journal of Molecular and Cellular Cardiology CrossRef
  5. Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity?
    Jenelle Govender et al, 2018, Toxicology and Applied Pharmacology CrossRef
  6. Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies
    J. Luis Espinoza et al, 2018, Blood Reviews CrossRef
  7. Health benefits of resveratrol: Evidence from clinical studies
    Akhand Pratap Singh et al, 2019, Med Res Rev CrossRef
  8. Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology
    Ibrahim Abdelgawad et al, 2019, Nutrients CrossRef
  9. null
    Luciana L. Ferreira et al, 2019 CrossRef
  10. Pharmacological properties of Rheum turkestanicum Janisch
    Ahmad Ghorbani et al, 2019, Heliyon CrossRef
  11. Blueberry extract attenuates doxorubicin-induced damage in H9c2 cardiac cells
    Yue Sun et al, 2019, Can. J. Physiol. Pharmacol. CrossRef
  12. The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction
    Vernon W. Dolinsky, 2017 CrossRef
  13. Molecular mechanisms in cardiomyopathy
    Keith Dadson et al, 2017 CrossRef
  14. Doxorubicin persistently rewires cardiac circadian homeostasis in mice
    Luciana L. Ferreira et al, 2019, Arch Toxicol CrossRef
  15. The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
    Kerstin N Timm et al, 2020, Cardiovasc Drugs Ther CrossRef
  16. Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
    Abeer M. Alanazi et al, 2020, Antioxidants CrossRef
  17. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes
    Shishir Upadhyay et al, 2020, Journal of Ethnopharmacology CrossRef
  18. Cardiotoxicity of doxorubicin-based therapy: What is the protective cognition that phytochemicals provide us?
    Cun Liu et al, 2020, Pharmacological Research CrossRef
  19. CYP1B1 as a therapeutic target in cardio-oncology
    Alexa N. Carrera et al, 2020 CrossRef
  20. Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms
    Keith Dadson et al, 2020 CrossRef
  21. Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1
    Sheng Zhang et al, 2021, DDDT CrossRef
  22. Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways
    Jie Wang(a) et al, 2021, Cell. Mol. Life Sci. CrossRef
  23. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction
    Xiaodong Zhuang et al, 2021, Mechanisms of Ageing and Development CrossRef
  24. Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity
    David S. Monahan et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  25. Resveratrol and endothelial function: a literature review
    Negin Parsamanesh et al, 2021, Pharmacological Research CrossRef
  26. Anthracycline chemotherapy‐mediated vascular dysfunction as a model of accelerated vascular aging
    Zachary S. Clayton et al, 2021, Aging and Cancer CrossRef
  27. A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
    Li-Feng Hu et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  28. The modulation of SIRT1 and SIRT3 by natural compounds as a therapeutic target in doxorubicin‐induced cardiotoxicity: A review
    Fatemeh B. Tabrizi et al, 2021, J Biochem Mol Toxicol CrossRef
  29. Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
    Mohammad Sheibani et al, 2022, Cardiovasc Toxicol CrossRef
  30. Nicotinic Acid Riboside Regulates Nrf-2/P62-Related Oxidative Stress and Autophagy to Attenuate Doxorubicin-Induced Cardiomyocyte Injury
    Linfeng Zou et al, 2022, BioMed Research International CrossRef
  31. Neferine attenuates doxorubicin-induced fibrosis and hypertrophy in H9c2 cells.
    Bharathi Priya Lohanathan et al, 2022, J Biochem Mol Toxicol CrossRef
  32. Novel Therapeutics for Anthracycline Induced Cardiotoxicity
    Jacqueline T. Vuong et al, 2022, Front. Cardiovasc. Med. CrossRef
  33. Extracorporeal shock waves protect cardiomyocytes from doxorubicin-induced cardiomyopathy by upregulating survivin via the integrin-ILK-Akt-Sp1/p53 axis
    Ji Yoon Lee et al, 2019, Sci Rep CrossRef
  34. Resveratrol alleviated 5-FU-induced cardiotoxicity by attenuating GPX4 dependent ferroptosis
    Dongning Li et al, 2023, The Journal of Nutritional Biochemistry CrossRef